tiprankstipranks
Advertisement
Advertisement

CAMP Stock Latest News

CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan
Company AnnouncementsCAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan
3d ago
8K
CAMP
Camp4 Therapeutics initiated with a Buy at Chardan
PremiumThe Fly
Camp4 Therapeutics initiated with a Buy at Chardan
6d ago
CAMP
CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy
PremiumCompany Announcements
CAMP4 Highlights Preclinical Progress of SYNGAP1 Therapy
1M ago
8K
CAMP
Buy Rating Reaffirmed on CAMP4 as CMP-002 Advances Toward 2026 SYNGAP1 Trial and Strong Cash Runway Extends Into 2028
PremiumRatings
Buy Rating Reaffirmed on CAMP4 as CMP-002 Advances Toward 2026 SYNGAP1 Trial and Strong Cash Runway Extends Into 2028
1M ago
CAMP
Camp4 Therapeutics reports Q1 EPS (32c), consensus (21c)
PremiumThe Fly
Camp4 Therapeutics reports Q1 EPS (32c), consensus (21c)
1M ago
CAMP
Camp4 Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe FlyCamp4 Therapeutics initiated with a Buy at Rodman & Renshaw
2M ago
CAMP
Camp4 Therapeutics price target raised to $9 from $8 at Leerink
Premium
The Fly
Camp4 Therapeutics price target raised to $9 from $8 at Leerink
2M ago
CAMP
CAMP4 Therapeutics Adds Veteran CFO MacLean to Board
Premium
Company Announcements
CAMP4 Therapeutics Adds Veteran CFO MacLean to Board
3M ago
8K
CAMP
CAMP Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CAMP Earnings this Week: How Will it Perform?
3M ago
CAMP
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
CAMP
SPRB
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
CAMP
CAMP4 Highlights 2025 Results and SYNGAP1 Program Progress
PremiumCompany Announcements
CAMP4 Highlights 2025 Results and SYNGAP1 Program Progress
3M ago
8K
CAMP
Camp4 Therapeutics participates in a conf call hosted by Cantor Fitzgerald
PremiumThe FlyCamp4 Therapeutics participates in a conf call hosted by Cantor Fitzgerald
4M ago
CAMP
CAMP4 Therapeutics updates corporate investor presentation materials
Premium
Company Announcements
CAMP4 Therapeutics updates corporate investor presentation materials
5M ago
8K
CAMP
CAMP4 Therapeutics Restructures Leases and Expands Facilities
Premium
Company Announcements
CAMP4 Therapeutics Restructures Leases and Expands Facilities
6M ago
8K
CAMP
CAMP4 Therapeutics: GSK Collaboration and Strengthened Funding Base De-Risk CMP-002 Development and Support Buy Rating
PremiumRatings
CAMP4 Therapeutics: GSK Collaboration and Strengthened Funding Base De-Risk CMP-002 Development and Support Buy Rating
6M ago
CAMP
CAMP4 Therapeutics Announces $28 Million Common Stock Offering
PremiumCompany Announcements
CAMP4 Therapeutics Announces $28 Million Common Stock Offering
6M ago
8K
CAMP
External Validation and Strengthened Balance Sheet Underpin Buy Rating on CAMP4 Therapeutics
PremiumRatings
External Validation and Strengthened Balance Sheet Underpin Buy Rating on CAMP4 Therapeutics
6M ago
CAMP
CAMP4, GSK form RNA therapeutics collaboration agreement
PremiumCompany Announcements
CAMP4, GSK form RNA therapeutics collaboration agreement
6M ago
8K
CAMP
Camp4 Therapeutics prices 5M shares at $6.00 in underwritten public offering
PremiumThe FlyCamp4 Therapeutics prices 5M shares at $6.00 in underwritten public offering
6M ago
CAMP
Camp4 Therapeutics 5M share Secondary priced at $6.00
Premium
The Fly
Camp4 Therapeutics 5M share Secondary priced at $6.00
6M ago
CAMP
Camp4 Therapeutics, GSK enter strategic collaboration
Premium
The Fly
Camp4 Therapeutics, GSK enter strategic collaboration
6M ago
GSK
CAMP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >